Beneficial outcome of early dietary lysine restriction as an adjunct to pyridoxine therapy in a child with pyridoxine dependant epilepsy due to Antiquitin deficiency

JIMD Reports
Maina P KavaShanti Balasubramaniam

Abstract

Pyridoxine-dependent epilepsy (PDE) is a potentially treatable vitamin-responsive epileptic encephalopathy. The most prevalent form of PDE is due to an underlying genetic defect in ALDH7A1 encoding Antiquitin (ATQ), an enzyme with α-aminoadipic semialdehyde dehydrogenase (AASADH) activity which facilitates cerebral lysine degradation. Devastating outcomes including intellectual disability and significant developmental delays are still observed in 75% to 80% of pyridoxine responsive individuals with good seizure control, potentially attributable to the accumulation of toxic intermediates α-aminoadipic semialdehyde (AASA) and its cyclic form Δ1-piperideine-6-carboxylate (P6C) in plasma, urine and CSF. Thus, adjunct treatment strategies incorporating lysine restriction and arginine supplementation, separately or in combination with pyridoxine have been attempted to enhance seizure control and improve cognitive function. We describe a 4 year old girl with classical PDE who demonstrated significant improvements in clinical, neurological and developmental outcomes including absence of clinical seizures and cessation of antiepileptic medications since age 3 months, normalisation of EEG, significant improvement in the white matter sign...Continue Reading

References

Jul 23, 1998·Neurology·S M Gospe, S T Hecht
Jul 6, 2004·Molecular Genetics and Metabolism·Antonella PedutoJean-Marie Saudubray
Jun 10, 2005·Neuropediatrics·B PleckoS Stöckler-Ipsiroglu
Feb 24, 2006·Nature Medicine·Philippa B MillsPeter T Clayton
Mar 30, 2006·American Journal of Physiology. Endocrinology and Metabolism·Robyn L O'KaneRichard A Hawkins
Mar 9, 2010·The Journal of Biological Chemistry·Chad BrockerVasilis Vasiliou
Jun 18, 2010·Brain : a Journal of Neurology·Philippa B MillsPeter T Clayton
Oct 7, 2010·Brain : a Journal of Neurology·Sven W SauerStefan Kölker
Feb 23, 2011·Chemico-biological Interactions·Chad BrockerVasilis Vasiliou
Jul 19, 2012·Developmental Medicine and Child Neurology·Levinus A BokMichèl A Willemsen
Oct 2, 2012·Molecular Genetics and Metabolism·Clara D M van KarnebeekSylvia Stockler
Aug 16, 2014·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Saadet Mercimek-MahmutogluEva Mamak
Mar 21, 2016·Pediatric Neurology·Clara D M van KarnebeekSylvia Stockler-Ipsiroglu
Nov 25, 2016·Metabolic Brain Disease·Amal Al TeneijiSaadet Mercimek-Mahmutoglu
Apr 1, 2014·Molecular Genetics and Metabolism Reports·Saadet Mercimek-MahmutogluLianna Kyriakopoulou
Jul 15, 2018·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Irene ToldoAlessandra Murgia
Jan 1, 2017·Expert Review of Endocrinology & Metabolism·Izabella Agostinho PenaClara D M Van Karnebeek

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.